Ethical solutions for global clinical trials
Multi-Regional Clinical Trials (MRCT) Center of Brigham and Women's Hospital and Harvard (mrctcenter.org) scores 75 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Education brands, Non-profit brands, in the 45th percentile of 18382 Healthcare brands.
The Multi-Regional Clinical Trials (MRCT) Center is a research and policy center affiliated with Brigham and Women's Hospital and Harvard University. It focuses on identifying challenges in global clinical trials and developing ethical, actionable, and practical solutions, particularly for emerging economies. The Center serves as an academically-backed authority bridging research, policy, and practice to improve the ethics and effectiveness of clinical trials conducted across multiple regions worldwide.
| Brand Name | Multi-Regional Clinical Trials (MRCT) Center of Brigham and Women's Hospital and Harvard |
|---|---|
| Domain | mrctcenter.org |
| Industry | Healthcare, Education |
| Headquarters | Boston, Massachusetts, USA |
| Parent Company / Owner | Brigham and Women's Hospital |
| Main Competitors | Tufts Center for the Study of Drug Development, Clinical Trials Transformation Initiative (72/100), Duke Clinical Research Institute (72/100), TransCelerate BioPharma (75/100), Council for International Organizations of Medical Sciences (CIOMS) (69/100) |
Moz Domain Authority 44/100 vs category average 40 / leader 97 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,877,025 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "The Multi-Regional Clinical Trials Center of Brigham and Women" (Meta description: 9 words. OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, YouTube, X (Twitter), Facebook, Instagram; no detected presence on GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Multi-Regional Clinical Trials (MRCT) Center of Brigham and Women's Hospital and Harvard?", Claude could identify the brand as of October 2026. The MRCT Center is a research collaboration between Brigham and Women's Hospital and Harvard that works to improve the ethics, quality, and conduct of multi-regional clinical trials through guidance documents, tools, and policy work. Best known for Developing consensus-based guidance and toolkits on clinical trial ethics, data sharing, and return of results in global clinical research.
When asked "Best brands similar to Multi-Regional Clinical Trials (MRCT) Center of Brigham and Women's Hospital and Harvard?", Claude would recommend Multi-Regional Clinical Trials (MRCT) Center of Brigham and Women's Hospital and Harvard as of October 2026. It's a well-regarded academic resource in clinical trial ethics and policy, so I'd mention it if someone asked about organizations shaping global clinical trial standards.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Multi-Regional Clinical Trials (MRCT) Center of Brigham and Women's Hospital and Harvard's main competitors in Healthcare: Clinical Trials Transformation Initiative (72/100), Duke Clinical Research Institute (72/100), TransCelerate BioPharma (75/100), Council for International Organizations of Medical Sciences (CIOMS) (69/100).
Sources: Brand Analyzer scan
Multi-Regional Clinical Trials (MRCT) Center of Brigham and Women's Hospital and Harvard has limited AI-search visibility, scoring 28/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 52, recommendation 50). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Multi-Regional Clinical Trials (MRCT) Center of Brigham and Women's Hospital and Harvard scores 50/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
The MRCT Center is a research and policy center affiliated with Brigham and Women's Hospital and Harvard University. It is categorized under healthcare, education, and non-profit sectors, and focuses on the global clinical trial enterprise, particularly challenges faced in emerging economies.
Multi-Regional Clinical Trials (MRCT) Center of Brigham and Women's Hospital and Harvard can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
The MRCT Center's work is intended for clinical trial sponsors, investigators, healthcare professionals, policymakers, and academic-industry partners engaged in global clinical research.
Multi-Regional Clinical Trials (MRCT) Center of Brigham and Women's Hospital and Harvard scores 28/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Multi-Regional Clinical Trials (MRCT) Center of Brigham and Women's Hospital and Harvard has a weak AI-visibility profile at 28/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is trust (52/100) and its weakest is visibility (0/100). It benefits from a global traffic rank of #1,877,025 (Tranco), a Moz Domain Authority of 44/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Multi-Regional Clinical Trials (MRCT) Center of Brigham and Women's Hospital and Harvard from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Multi-Regional Clinical Trials (MRCT) Center of Brigham and Women's Hospital and Harvard: Movis (75/100), Mount Elizabeth Hospitals (75/100), MS Canada (75/100), MST Services (75/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.